Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic ...

Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the associated factor EMP1 in the progression of resectable pancreatic cancer ...

Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in ...

Dan, diagnosed with stage 4 pancreatic cancer, shares his journey to remission and insights on clinical trials and patient ...

A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research ...

Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...

Immorta Bio today announced the publication of a landmark preclinical study in the Journal of Translational Medicine demonstrating that its novel immunotherapy, SenoVax(TM), dramatically reduces ...

Pancreatic cancer remains the deadliest cancer due to late diagnosis and poor CT visibility, leaving just 10% alive at five years.